Fundraising Fox
Strata Oncology
Ann Arbor, US · Founded 2015 · Delaware corporation · 29 employees on LinkedIn · 8 known investors
Find your way into Strata Oncology
Sign up to see every warm intro you have to Strata Oncology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Strata Oncology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Strata Oncology develops precision oncology biomarkers and predictive diagnostic tools for cancer treatment, including treatment response scores for antibody-drug conjugates (ADCs) and an Immunotherapy Response Score for anti-PD-1/PD-L1 therapies. Its algorithms combine measures such as tumor mutation burden and gene expression to help match patients to the most suitable therapy.
Founders & leadership
Strata Oncology was founded in 2015 by Daniel Rhodes, Dan Rhodes, and Scott Tomlins.
Board
Investors · 8
How we know: Arboretum Ventures's portfolio page · board seat on SEC Form D · press coverage · the VCSheet dataset · Not right? Tell us
How we know: Baird Capital's portfolio page · press coverage · Not right? Tell us
How we know: Merck Global Health Innovation Fund's portfolio page · funding news · press coverage · Not right? Tell us
How we know: MSD Global Health Innovation Fund's portfolio page · Not right? Tell us
How we know: Pfizer Venture Investments's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
Funding
SEC filings, press & company announcements$29.2M disclosed across 4 of 5 rounds · 2016–2024
- Undisclosed amountSeries CJul 2021Source ↗
▶$6.1MraisedNov 2024 · 14 investors · OtherRule 506(b)
- Matthew MartinExecutive Officer
- Daniel RhodesExecutive Officer, Director
- Keith FlahertyDirector
- Christopher O'DonnellDirector
- Jeffrey WilliamsExecutive Officer, Director
- David RubinDirector
- James PavlikDirector
- Jan GarfinkleDirector
- Offering amount
- $10M
- Amount sold
- $6.1M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedNov 2020 · 9 investors · OtherRule 506(b)
- William BurkothDirector
- Prem TumkositDirector
- Jeffrey WilliamsExecutive Officer, Director
- Jan GarfinkleDirector
- Daniel RhodesExecutive Officer, Director
- Matthew MartinExecutive Officer
- Nicole WalkerDirector
- Keith FlahertyDirector
- Offering amount
- $10M
- Amount sold
- $5M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.8MraisedMay 2018 · 7 investors · OtherRule 506(b)
- Prem TumkositDirector
- Matthew MartinExecutive Officer
- Keith FlahertyDirector
- William BurkothDirector
- Nicole WalkerDirector
- Jeffrey WilliamsDirector
- Jan GarfinkleDirector
- Daniel RhodesExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $11.8M
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$6.3MraisedMar 2016 · 6 investors · OtherRule 506(b)
- Matthew MartinExecutive Officer
- Jeffrey WilliamsDirector
- Daniel RhodesExecutive Officer, Director
- Offering amount
- $12.3M
- Amount sold
- $6.3M
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Strata Oncology.
In the news
Frequently asked questions
- What does Strata Oncology do?
- Strata Oncology develops precision oncology biomarkers and predictive diagnostic tools for cancer treatment, including treatment response scores for antibody-drug conjugates (ADCs) and an Immunotherapy Response Score for anti-PD-1/PD-L1 therapies. Its algorithms combine measures such as tumor mutation burden and gene expression to help match patients to the most suitable therapy.
- Who founded Strata Oncology?
- Strata Oncology was founded by Daniel Rhodes, Dan Rhodes, Scott Tomlins in 2015.
- Who are Strata Oncology's investors?
- Strata Oncology's investors include Arboretum Ventures, Baird Capital, Merck Global Health Innovation Fund, MSD Global Health Innovation Fund, Pfizer Venture Investments, Wellington Management, Deerfield Management Company, Pfizer Ventures.
- How much funding has Strata Oncology raised?
- Strata Oncology has disclosed $29.2M raised across 4 of its 5 known rounds.
- Where is Strata Oncology headquartered?
- Strata Oncology is headquartered in Ann Arbor, US.